| Name | ADAPTIN BIO, INC. |
|---|---|
| CIK | 0001938571 |
| Tickers | APTN |
| Exchanges | OTC |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 881566415 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (888) 609-1498 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
78 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-17 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-26-121396 | 333-298622 | 261566073 | 33 | 436854 | |||
| 2026-11-17 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-26-121395 | 333-287338 | 261566071 | 33 | 436778 | |||
| 2026-11-13 | 10-Q | QUARTERLY REPORT | 0001213900-26-119688 | 000-56583 | 261552413 | 34 | 4453857 | 1 | 1 | |
| 2026-09-10 | 424B3 | PROSPECTUS | 0001213900-26-098801 | 333-298622 | 261371279 | 33 | 1552147 | |||
| 2026-09-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002923 | 333-298622 | 261370093 | 33 | 1877 | ||
| 2026-08-28 | S-1 | REGISTRATION STATEMENT | 0001213900-26-095034 | 333-298622 | 261339981 | 33 | 12721560 | 1 | 1 | |
| 2026-08-25 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-26-093549 | 333-287338 | 261316328 | 33 | 47795 | |||
| 2026-08-25 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-26-093520 | 000-56583 | 261315812 | 34 | 209790 | 1 | 1 |
| 2026-08-20 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-26-092107 | 333-287338 | 261299983 | 33 | 488304 | |||
| 2026-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-26-089081 | 000-56583 | 261273204 | 34 | 4416994 | 1 | 1 | |
| 2026-07-22 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-002384 | 333-287338 | 261195063 | 33 | 1890 | ||
| 2026-07-21 | POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 | 0001213900-26-080096 | 333-287338 | 261190985 | 33 | 7415077 | 1 | 1 | |
| 2026-06-22 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001938571-26-000004 | 021-568890 | 261107640 | 33 | 13933 | ||
| 2026-06-12 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-26-068357 | 333-287338 | 261087745 | 33 | 113176 | |||
| 2026-06-12 | 10-K/A | AMENDMENT NO. 1 TO FORM 10-K | 0001213900-26-068261 | 000-56583 | 261086569 | 34 | 263115 | 1 | 1 | |
| 2026-05-18 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-26-058479 | 333-287338 | 26993987 | 33 | 1701077 | |||
| 2026-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-26-057188 | 000-56583 | 26982782 | 34 | 3709609 | 1 | 1 | |
| 2026-04-06 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-26-040458 | 000-56583 | 26841188 | 34 | 199335 | 1 | 1 |
| 2026-04-01 | 10-K | ANNUAL REPORT | 0001213900-26-038568 | 000-56583 | 26828871 | 34 | 5900917 | 1 | 1 | |
| 2026-04-01 | NT 10-K | NOTIFICATION OF LATE FILING | 0001213900-26-038402 | 000-56583 | 26827092 | 34 | 20636 | |||
| 2026-03-23 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001938571-26-000003 | 021-568890 | 26781489 | 33 | 13838 | ||
| 2026-02-20 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001938571-26-000002 | 021-568890 | 26658696 | 33 | 13742 | ||
| 2026-01-05 | D | xslFormDX01/primary_doc.xml | 06b | 0001938571-26-000001 | 021-568890 | 26506111 | 33 | 13363 | ||
| 2025-12-23 | 8-K | CURRENT REPORT | 1.01,3.02 | 0001213900-25-125451 | 000-56583 | 251601623 | 34 | 193929 | 1 | 1 |
| 2025-11-17 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-25-111384 | 333-287338 | 251490129 | 33 | 519315 | |||
| 2025-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-25-110559 | 000-56583 | 251483651 | 34 | 3981895 | 1 | 1 | |
| 2025-10-07 | 424B3 | PROSPECTUS SUPPLEMENT | 0001213900-25-097028 | 333-287338 | 251379855 | 33 | 65945 | |||
| 2025-10-06 | 8-K | CURRENT REPORT | 5.02,8.01,9.01 | 0001213900-25-096532 | 000-56583 | 251376905 | 34 | 230188 | 1 | 1 |
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086588 | 5543 | ||||||
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086586 | 5588 | ||||||
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086585 | 5560 | ||||||
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086583 | 6189 | ||||||
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086582 | 6170 | ||||||
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086581 | 5688 | ||||||
| 2025-09-10 | 4 | PRIMARY DOCUMENT | 0001213900-25-086580 | 5630 | ||||||
| 2025-08-15 | S-8 | REGISTRATION STATEMENT | 0001213900-25-077209 | 333-289627 | 251223519 | 33 | 194234 | 1 | 1 | |
| 2025-08-15 | 424B3 | 424B3 | 0001213900-25-077176 | 333-287338 | 251223279 | 33 | 403609 | |||
| 2025-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-25-076361 | 000-56583 | 251216722 | 34 | 2971298 | 1 | 1 | |
| 2025-08-05 | 424B3 | PROSPECTUS | 0001213900-25-071970 | 333-287338 | 251184304 | 33 | 1946842 | |||
| 2025-08-04 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002464 | 333-287338 | 251182584 | 33 | 1877 | ||
| 2025-07-31 | CORRESP | filename1.htm | 0001213900-25-069774 | 7425 | ||||||
| 2025-07-28 | CORRESP | filename1.htm | 0001213900-25-068142 | 26130 | ||||||
| 2025-07-28 | S-1/A | AMENDMENT NO. 2 TO FORM S-1 | 0001213900-25-068130 | 333-287338 | 251155202 | 33 | 6456528 | 1 | 1 | |
| 2025-07-16 | UPLOAD | filename1.pdf | 0000000000-25-007475 | 333-287338 | 45459 | |||||
| 2025-06-27 | CORRESP | filename1.htm | 0001213900-25-058971 | 93347 | ||||||
| 2025-06-27 | S-1/A | AMENDMENT NO. 1 TO FORM S-1 | 0001213900-25-058957 | 333-287338 | 251085846 | 33 | 9838574 | 1 | 1 | |
| 2025-06-13 | UPLOAD | filename1.pdf | 0000000000-25-006275 | 333-287338 | 58665 | |||||
| 2025-05-16 | S-1 | REGISTRATION STATEMENT | 0001213900-25-044585 | 333-287338 | 25956872 | 33 | 5958079 | 1 | 1 | |
| 2025-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-25-044083 | 000-56583 | 25951734 | 34 | 2955649 | 1 | 1 | |
| 2025-04-15 | 10-K | ANNUAL REPORT | 0001213900-25-031878 | 000-56583 | 25838618 | 34 | 3311960 | 1 | 1 | |
| 2025-04-15 | 8-K/A | AMENDMENT NO. 1 TO FORM 8-K | 2.01,9.01 | 0001213900-25-031875 | 000-56583 | 25838600 | 34 | 659619 | 1 | 1 |
| 2025-04-09 | 8-K | CURRENT REPORT | 8.01,9.01 | 0001213900-25-030320 | 000-56583 | 25825551 | 34 | 214560 | 1 | 1 |
| 2025-03-31 | NT 10-K | NOTIFICATION OF LATE FILING | 0001213900-25-026302 | 000-56583 | 25793759 | 34 | 24063 | |||
| 2025-02-26 | D | xslFormDX01/primary_doc.xml | 06b | 0001578563-25-000148 | 021-539301 | 25669510 | 33 | 15440 | ||
| 2025-02-18 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-014978 | 005-94821 | 25636658 | 34 | 10062 | |||
| 2025-02-18 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-25-014977 | 005-94821 | 25636647 | 34 | 9943 | |||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014974 | 6525 | ||||||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014973 | 7143 | ||||||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014971 | 6502 | ||||||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014970 | 7085 | ||||||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014969 | 6585 | ||||||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014968 | 6526 | ||||||
| 2025-02-18 | 3 | PRIMARY DOCUMENT | 0001213900-25-014967 | 6580 | ||||||
| 2025-02-18 | 8-K | CURRENT REPORT | 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,9.01 | 0001213900-25-014630 | 000-56583 | 25633035 | 34 | 5670293 | 1 | 1 |
| 2025-02-13 | 4 | xslF345X05/ownership.xml | 0001213900-25-013732 | 5401 | ||||||
| 2025-01-29 | SC 14F1 | SCHEDULE 14F-1 | 0001213900-25-007939 | 005-94821 | 25570399 | 34 | 116289 | |||
| 2024-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-24-098361 | 000-56583 | 241461233 | 34 | 1550600 | 1 | 1 | |
| 2024-08-14 | 10-Q | QUARTERLY REPORT | 0001213900-24-068816 | 000-56583 | 241206221 | 34 | 1559089 | 1 | 1 | |
| 2024-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-24-043492 | 000-56583 | 24949668 | 34 | 1384811 | 1 | 1 | |
| 2024-04-01 | 10-K | ANNUAL REPORT | 0001213900-24-028681 | 000-56583 | 24808924 | 34 | 1995533 | 1 | 1 | |
| 2023-11-30 | 3 | xslF345X02/ownership.xml | 0001213900-23-091523 | 2864 | ||||||
| 2023-11-30 | 3 | xslF345X02/ownership.xml | 0001213900-23-091517 | 3963 | ||||||
| 2023-11-20 | UPLOAD | filename1.pdf | 0000000000-23-012676 | 39831 | ||||||
| 2023-11-14 | 10-Q | QUARTERLY REPORT | 0001213900-23-086982 | 000-56583 | 231406715 | 34 | 1334191 | 1 | 1 | |
| 2023-10-06 | CORRESP | filename1.htm | 0001013762-23-002586 | 47081 | ||||||
| 2023-10-06 | 10-12G/A | AMENDMENT NO.1 TO FORM 10-12G | 0001013762-23-002582 | 000-56583 | 231315011 | 34 | 298666 | |||
| 2023-09-07 | UPLOAD | filename1.pdf | 0000000000-23-009873 | 51259 | ||||||
| 2023-08-10 | 10-12G | GENERAL FORM FOR REGISTRATION OF SECURITIES | 0001213900-23-065715 | 000-56583 | 231160741 | 34 | 435419 |
One latest value per concept from companyfacts (152 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 9.26M | 2026-11-12 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 9.30M | 2025-06-30 | 2025 | FY | 10-K/A | 2026-06-12 | 0001213900-26-068261 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 364.23 | 2026-08-25 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 364.23 | 2026-08-25 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 2.64M | 2026-08-25 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-25 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-25 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 5,890 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 1.69M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | AccountsPayableOtherCurrentAndNoncurrent | Accounts Payable, Other | USD | 313,850 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 990,185 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 15,460 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 25,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 10.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 36,435 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 496,864 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 53,722 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 2.58M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001213900-25-110559 |
| us-gaap | Assets | Assets | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | BusinessCombinationAcquisitionRelatedCosts | Business Combination, Acquisition Related Costs | USD | 1.68M | 2026-01-01 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | Cash | Cash | USD | 1.35M | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-14 | 0001213900-25-076361 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 430,333 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 430,333 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -28,841 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | CashFDICInsuredAmount | Cash, FDIC Insured Amount | USD | 250,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 4.96 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001213900-25-110559 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 132,570 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 2.61M | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | CommonStockCapitalSharesReservedForFutureIssuance | Common Stock, Capital Shares Reserved for Future Issuance | shares | 1.48M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001213900-25-110559 | |
| us-gaap | CommonStockConvertibleConversionPriceIncrease | Common Stock, Convertible, Conversion Price, Increase | USD/shares | 3.3 | 2026-01-01 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 9.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 9.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 926 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | ConversionOfStockSharesConverted1 | Conversion of Stock, Shares Converted | shares | 501,140 | 2026-01-01 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 1.25M | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 3,750 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001213900-24-098361 |
| us-gaap | DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1 | Debt Conversion, Converted Instrument, Warrants or Options Issued | shares | 132,570 | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0001213900-25-044083 |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 193,876 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredFinanceCostsGross | Debt Issuance Costs, Gross | USD | 197,570 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredFinanceCostsOwnshareLendingArrangementIssuanceCostsNet | Deferred Finance Costs, Own-share Lending Arrangement, Issuance Costs, Net | USD | 193,876 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 2.02M | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 236,213 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 1.67M | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 85,817 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 6,879 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 113,173 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 3,127 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028681 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 6,879 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028681 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 2.02M | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts | Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs | USD | 31.00M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001213900-25-110559 | |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -6,312 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 551,269 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 544,957 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.37 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.37 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.243 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.018 | 2024-01-01 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.008 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0.102 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsOther | Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent | pure | 0.8 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028681 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 1.02M | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 2.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 6,312 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | FederalDepositInsuranceCorporationPremiumExpense | Federal Deposit Insurance Corporation Premium Expense | USD | 250,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-15 | 0001213900-24-043492 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | 326,345 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 2.88M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -3.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 58 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 1.11M | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -1.09M | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount | USD | 55,270 | 2024-01-01 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 40,334 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -453,445 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-04-01 | 0001213900-26-038568 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 161,293 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 393,720 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | -32,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | 14,190 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | IncreaseDecreaseInNotesPayableCurrent | Increase (Decrease) in Notes Payable, Current | USD | 22,568 | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0001213900-23-086982 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 148,531 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 230,838 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | InterestExpenseDebt | Interest Expense, Debt | USD | 9,605 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 9,605 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 9,605 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 134,875 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | IssuanceOfStockAndWarrantsForServicesOrClaims | Issuance of Stock and Warrants for Services or Claims | USD | 250,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | Liabilities | Liabilities | USD | 2.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 1.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 2.76M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 1.98M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -2.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -3.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | NoncashOrPartNoncashAcquisitionPayablesAssumed1 | Noncash or Part Noncash Acquisition, Payables Assumed | USD | 80,915 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-04-01 | 0001213900-24-028681 |
| us-gaap | NoninterestExpenseDirectorsFees | Noninterest Expense Directors Fees | USD | 9,000 | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0001213900-24-098361 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -9,605 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | NotesPayable | Notes Payable | USD | 81,219 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-15 | 0001213900-24-043492 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 81,219 | 2023-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 12,576 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0001213900-25-044083 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 31,353 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-14 | 0001213900-24-068816 |
| us-gaap | OtherGeneralAndAdministrativeExpense | Other General and Administrative Expense | USD | 180,000 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | OtherNotesPayableCurrent | Other Notes Payable, Current | USD | 275,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | OtherPrepaidExpenseCurrent | Other Prepaid Expense, Current | USD | 12,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 1.46M | 2025-01-01 | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0001213900-25-044083 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 127,510 | 2024-01-01 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 215,746 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 657,307 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 404,808 | 2026-03-31 | POS AM | 2026-07-21 | 0001213900-26-080096 | |||
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 216,020 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 912,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 6.16M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | ProceedsFromIssuanceOrSaleOfEquity | Proceeds from Issuance or Sale of Equity | USD | 582,961 | 2025-12-22 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 1.00M | 2024-01-01 | 2024-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | ProceedsFromRepaymentsOfNotesPayable | Proceeds from (Repayments of) Notes Payable | USD | -139,172 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 1.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 275,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 419,700 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -12.60M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 4 | 2025-10-29 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 52,000 | 2026-06-09 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 723,561 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.25 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.823 | 2026-01-01 | 2026-03-31 | POS AM | 2026-07-21 | 0001213900-26-080096 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.039 | 2026-01-01 | 2026-03-31 | POS AM | 2026-07-21 | 0001213900-26-080096 | ||
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 164,770 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-14 | 0001213900-25-110559 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 3.53 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 109,846 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | -1.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 | |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 250,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 202,621 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 184,359 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 801,309 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 112,155 | 2025-12-31 | S-1 | 2026-08-28 | 0001213900-26-095034 | |||
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 50,387 | 2024-12-31 | 2024 | FY | 10-K | 2025-04-15 | 0001213900-25-031878 | |
| us-gaap | WarrantExercisePriceDecrease | Warrant, Exercise Price, Decrease | USD/shares | 3.3 | 2026-01-01 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | WarrantExercisePriceIncrease | Warrant, Exercise Price, Increase | USD/shares | 4.4 | 2026-01-01 | 2026-06-30 | S-1 | 2026-08-28 | 0001213900-26-095034 | ||
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 2.58M | 2025-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0001213900-25-044083 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 8.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 8.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-13 | 0001213900-26-119688 |